ARCHIMED

ArchiMed SAS is a private equity firm established in 2014, headquartered in Lyon, France, with additional offices in New York and Singapore. The firm specializes in investing in small to mid-cap companies within the healthcare sector, focusing on areas such as care and wellness, medtech, biopharma, and public health. ArchiMed targets investments in companies that generate revenues between €5 million and €100 million, although it can engage with larger firms. The firm typically commits between €5 million and €15 million per transaction, with the flexibility to invest amounts ranging from €2 million to over €50 million, either independently or alongside co-investors. ArchiMed primarily seeks to take both minority and majority stakes in unlisted companies, with a keen interest in opportunities across Western Europe and the United States. The firm's funding sources include its own team, as well as a network of European and American institutional and private investors, including successful healthcare entrepreneurs.